Craig S. Moore - Publications

Biomedical Sciences Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ploughman M, Eskes GA, Kelly LP, Kirkland MC, Devasahayam AJ, Wallack EM, Abraha B, Hasan SMM, Downer MB, Keeler L, Wilson G, Skene E, Sharma I, Chaves AR, Curtis ME, ... ... Moore CS, et al. Synergistic Benefits of Combined Aerobic and Cognitive Training on Fluid Intelligence and the Role of IGF-1 in Chronic Stroke. Neurorehabilitation and Neural Repair. 1545968319832605. PMID 30816066 DOI: 10.1177/1545968319832605  0.36
2016 Healy LM, Perron G, Won SY, Michell-Robinson MA, Rezk A, Ludwin SK, Moore CS, Hall JA, Bar-Or A, Antel JP. MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 26962228 DOI: 10.4049/Jimmunol.1502562  0.4
2016 Rao VT, Ludwin SK, Fuh SC, Sawaya R, Moore CS, Ho MK, Bedell BJ, Sarnat HB, Bar-Or A, Antel JP. MicroRNA Expression Patterns in Human Astrocytes in Relation to Anatomical Location and Age. Journal of Neuropathology and Experimental Neurology. PMID 26802178 DOI: 10.1093/Jnen/Nlv016  0.4
2015 Sénécal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, Moore CS, Prat A, Antel J, Arbour N. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. Glia. PMID 26649511 DOI: 10.1002/Glia.22948  0.4
2015 Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, Moore CS, Michel L, Althekair F, Rajasekharan S, Gommerman JL, Prat A, Fillatreau S, Bar-Or A. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Science Translational Medicine. 7: 310ra166. PMID 26491076 DOI: 10.1126/Scitranslmed.Aab4176  0.4
2015 Cao M, Cortes M, Moore CS, Leong SY, Durosier LD, Burns P, Fecteau G, Desrochers A, Auer RN, Barreiro LB, Antel JP, Frasch MG. Fetal microglial phenotype in vitro carries memory of prior in vivo exposure to inflammation. Frontiers in Cellular Neuroscience. 9: 294. PMID 26300730 DOI: 10.3389/Fncel.2015.00294  0.4
2015 Michell-Robinson MA, Touil H, Healy LM, Owen DR, Durafourt BA, Bar-Or A, Antel JP, Moore CS. Roles of microglia in brain development, tissue maintenance and repair. Brain : a Journal of Neurology. 138: 1138-59. PMID 25823474 DOI: 10.1093/Brain/Awv066  0.4
2015 Moore CS, Cui QL, Warsi NM, Durafourt BA, Zorko N, Owen DR, Antel JP, Bar-Or A. Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation. Journal of Immunology (Baltimore, Md. : 1950). 194: 761-72. PMID 25505283 DOI: 10.4049/Jimmunol.1401156  0.4
2014 Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nature Neuroscience. 17: 131-43. PMID 24316888 DOI: 10.1038/Nn.3599  0.4
2013 Wu C, Leong SY, Moore CS, Cui QL, Gris P, Bernier LP, Johnson TA, Séguéla P, Kennedy TE, Bar-Or A, Antel JP. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. Journal of Neuroinflammation. 10: 41. PMID 23509960 DOI: 10.1186/1742-2094-10-41  0.4
2013 Ijichi K, Brown GD, Moore CS, Lee JP, Winokur PN, Pagarigan R, Snyder EY, Bongarzone ER, Crocker SJ. MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology. Glia. 61: 765-77. PMID 23404611 DOI: 10.1002/Glia.22471  0.4
2013 Grant J, Parker K, Moore CS, Keddy PG, Mayne M, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein modulates multiple aspects of neuronal Ca2+ signaling. Neurochemical Research. 38: 847-56. PMID 23397285 DOI: 10.1007/S11064-013-0989-0  0.4
2012 Jr Ode F, Moore CS, Kennedy TE, Antel JP, Bar-Or A, Dhaunchak AS. MicroRNA dysregulation in multiple sclerosis. Frontiers in Genetics. 3: 311. PMID 23346094 DOI: 10.3389/Fgene.2012.00311  0.4
2012 Zhan H, Moore CS, Chen B, Zhou X, Ma XM, Ijichi K, Bennett MV, Li XJ, Crocker SJ, Wang ZW. Stomatin inhibits pannexin-1-mediated whole-cell currents by interacting with its carboxyl terminal. Plos One. 7: e39489. PMID 22768083 DOI: 10.1371/Journal.Pone.0039489  0.4
2012 Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, Bar-Or A, Antel JP. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia. 60: 717-27. PMID 22290798 DOI: 10.1002/Glia.22298  0.4
2012 Moore CS, Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology. The American Journal of Pathology. 180: 12-6. PMID 22033229 DOI: 10.1016/J.Ajpath.2011.09.008  0.4
2011 Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6247-54. PMID 21508247 DOI: 10.1523/Jneurosci.5474-10.2011  0.4
2011 Crocker SJ, Bajpai R, Moore CS, Frausto RF, Brown GD, Pagarigan RR, Whitton JL, Terskikh AV. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination. Neuropathology and Applied Neurobiology. 37: 643-53. PMID 21276029 DOI: 10.1111/J.1365-2990.2011.01165.X  0.4
2011 Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ. How factors secreted from astrocytes impact myelin repair. Journal of Neuroscience Research. 89: 13-21. PMID 20857501 DOI: 10.1002/Jnr.22482  0.4
2010 Hebb AL, Moore CS, Bhan V, Robertson GS. Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes. Autoimmune Diseases. 2011: 485752. PMID 21253524 DOI: 10.4061/2011/485752  0.4
2010 Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Current Drug Discovery Technologies. 7: 137-40. PMID 20836755 DOI: 10.2174/157016310793180611  0.4
2010 Wang J, Menchenton T, Yin S, Yu Z, Bance M, Morris DP, Moore CS, Korneluk RG, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice. Neurobiology of Aging. 31: 1238-49. PMID 18755525 DOI: 10.1016/J.Neurobiolaging.2008.07.016  0.4
2009 Thorne M, Moore CS, Robertson GS. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice. Journal of Neuroimmunology. 211: 92-100. PMID 19428125 DOI: 10.1016/J.Jneuroim.2009.04.003  0.4
2009 Alirezaei M, Fox HS, Flynn CT, Moore CS, Hebb AL, Frausto RF, Bhan V, Kiosses WB, Whitton JL, Robertson GS, Crocker SJ. Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy. 5: 152-8. PMID 19066443 DOI: 10.4161/Auto.5.2.7348  0.4
2008 Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). Journal of Neuroimmunology. 203: 79-93. PMID 18687476 DOI: 10.1016/J.Jneuroim.2008.06.030  0.4
2008 Hebb AL, Moore CS, Bhan V, Campbell T, Fisk JD, Robertson HA, Thorne M, Lacasse E, Holcik M, Gillard J, Crocker SJ, Robertson GS. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 577-94. PMID 18566024 DOI: 10.1177/1352458507087468  0.4
2008 Hebb AL, Moore CS, Bhan V, Robertson GS. Targeting apoptosis to treat multiple sclerosis. Current Drug Discovery Technologies. 5: 75-7. PMID 18537570 DOI: 10.2174/157016308783769432  0.4
2008 Moore CS, Hebb AL, Robertson GS. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes. Journal of Neuroimmunology. 193: 94-105. PMID 18055022 DOI: 10.1016/J.Jneuroim.2007.10.022  0.4
2007 Zehntner SP, Bourbonnière L, Moore CS, Morris SJ, Methot D, St Jean M, Lacasse E, Hebb AL, Robertson GS, Durkin J, Gillard JW, Owens T. X-linked inhibitor of apoptosis regulates T cell effector function. Journal of Immunology (Baltimore, Md. : 1950). 179: 7553-60. PMID 18025200 DOI: 10.4049/Jimmunol.179.11.7553  0.4
2006 Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis. The Journal of Pharmacology and Experimental Therapeutics. 319: 63-72. PMID 16809479 DOI: 10.1124/Jpet.106.106096  0.4
Show low-probability matches.